SAGE
SAGE Therapeutics Inc
Price:  
10.86 
USD
Volume:  
1,624,173.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAGE Probability of Bankruptcy

The Probability of Bankruptcy of SAGE Therapeutics Inc (SAGE) is 7.55% . This number represents the probability that SAGE will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating SAGE's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

SAGE - ESG ratings

ESG ratings are directly linked to the cost of capital and SAGE's ability to raise funding, both of which can significantly affect the probability of SAGE Therapeutics Inc going bankrupt.

ESG Score 67.40
Environment Score 70.28
Social Score 87.82
Governance Score 44.11
Returns
Historical Returns (5 day) -10.25%
Historical Returns (MTD) -22.09%
Historical Returns (YTD) -49.88%
Historical Returns (13 week) -52.18%
Historical Returns (26 week) -43.85%
Historical Returns (52 week) -78.10%
Efficiency
Asset Turnover 0.10
Receiveable Turnover 6.26
Gross Margin 83.94%
Operating Margin -1,489.18%
Pretax Margin -1,372.85%
Net Margin -1,372.85%
Return on Asset (ROA) -54.66
Return on Equity (ROE) -60.86
Return on Investments (ROI) -60.86
Price Metrics
Market Cap (M) 653.55
Enterprise Value (M)
52 Week High 59.98
52 Week Low 10.78
Beta 1.85
Average Volume (10 day) 0.67
Average Volume (3 month) 0.44
Price / Earnings (P/E)
Price / Sales (P/S) 7.33
Earnings
EPS -8.40
Revenue CAGR (5 year) -0.87%
Risk
Current Ratio 12.22
Quick Ratio 11.85